论文部分内容阅读
目的:观察米非司酮用于子宫内膜异位症腹腔镜术后的治疗效果。方法:将86例子宫内膜异位症腹腔镜术后患者随机分为两组,治疗组(米非司酮组)46例,对照组(单纯腹腔镜手术组)40例,比较两组症状缓解情况、复发率及妊娠率。结果:治疗组与对照组症状缓解率分别为91.30%、77.50%(P<0.01),复发率分别为15.22%、37.50%(P<0.01),受孕率分别为46.67%、16.67%(P<0.01)。结论:子宫内膜异位症术后联合米非司酮治疗能有效缓解症状,降低复发率,提高妊娠率,且不良反应小,宜于临床应用。
Objective: To observe the therapeutic effect of mifepristone for laparoscopic endometriosis. Methods: 86 cases of endometriosis after laparoscopic surgery were randomly divided into two groups, the treatment group (mifepristone group) 46 cases, the control group (simple laparoscopic surgery group) 40 cases, the two groups were compared Remission, relapse rate and pregnancy rate. Results: The rates of remission in treatment group and control group were 91.30% and 77.50% respectively (P <0.01). The recurrence rates were 15.22% and 37.50% respectively (P <0.01), and the pregnancy rates were 46.67% and 16.67% 0.01). Conclusion: Postoperative endometriosis combined with mifepristone treatment can effectively relieve symptoms, reduce the recurrence rate, improve the pregnancy rate, and the adverse reactions are small, suitable for clinical application.